from palo alto, hank greely, director center for the law and biosciences in stanford.lluck, who wrote the story for the "new york times." this is a remarkable story, a remarkable advance. we want to fully understand the potential and some of the caution being raised. i begin with pam belluck here. tell me the significance of this. >> so this is really a big deal. this is the closest that we have come to being able to genetically modify a human embryo. it was quite a successful experiment, or series of experiments, that the team did. that tells you that the ability to do that safely and to do that successfully is probably not all that far off. a number of years for sure, maybe a decade, but it's not all that far off. >> charlie: people with diseases that could be inherited, that issue can be eliminated? >> right. i mean, the goal is to be able to -- for couples who have mutations that they would pass on to their children, that would be a specific cause of a disease, the idea is that you would be able to correct this, to repair the mutation, to basically get rid of it. a